![Florian Reinaud](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Florian Reinaud
Direttore/Membro del Consiglio presso
SENSORION
Profilo
Florian Nicolas Christian Reinaud is the founder of Concilio.
Dr. Reinaud is currently Director at Sensorion SA, Director at Sensome SAS since 2017, and Non-Executive Director at Scancell Holdings Plc since 2024.
Former roles include Director at Kuros Biosurgery Holding AG, Director at Zealand Pharma A from 2010 to 2012, Director at Praxim SA, Director at Voluntis SA, Director at OMNI Orthopaedics, Inc., Director at FAB Pharma SAS, Director at Hansa Biopharma AB from 2024 to 2025, Investment Manager at Altaroc Partners SA in 2008, Analyst at Schroder Salomon Smith Barney, General Partner at Innovation Capital SASU from 2014 to 2015, Chief Financial Officer at DBV Technologies SA, and Analyst at Schroder Salomon Smith Barney International Ltd. in 2003.
Education includes undergraduate studies at the University of Oxford and a doctorate from Imperial College London.
Posizioni attive di Florian Reinaud
| Società | Posizione | Inizio |
|---|---|---|
| SENSORION | Direttore/Membro del Consiglio | - |
| SCANCELL HOLDINGS PLC | Direttore/Membro del Consiglio | 10/07/2024 |
Sensome SAS
 Sensome SAS Electronic Equipment/InstrumentsElectronic Technology Develops remote monitoring invasive vascular medical devices | Direttore/Membro del Consiglio | 01/06/2017 |
Precedenti posizioni note di Florian Reinaud
| Società | Posizione | Fine |
|---|---|---|
| HANSA BIOPHARMA AB | Direttore/Membro del Consiglio | 02/09/2025 |
Innovation Capital SASU
 Innovation Capital SASU Investment ManagersFinance Innovation Capital is an active manager which specializes in technology venture capital, investing in both early- and late-stage businesses with distinctive technology and high-growth potential, within the information technology and life sciences industries. They have invested in sectors including information and communication technologies, clean technologies, advanced materials, robotics, healthcare, biotechnologies and medical technologies. The firm seeks to invest in companies with a dynamic management team with execution capacity, a sizeable growth market, immediate user relevance, competitive advantages, reasonable development cost, intellectual property potential, and a sustainable business model. Innovation Capital aims to foster the growth of their investee companies through advisory consulting and networking opportunities. They lead the first and subsequent financing round or co-invest in re-financing rounds. They follow a pragmatic investment approach, are actively involved in the management of their investee companies and seek board representation. | Investitore di Private Equity | 30/07/2015 |
Altaroc Partners SA
 Altaroc Partners SA Investment ManagersFinance Altaroc Partners invests in companies located across the globe primarily in Europe and North America. The firm targets companies operating in the fields of technology, healthcare, b2b services and digital consumer. It provides financing for LBO's and buyout transactions. It also makes co-investments. | Investitore di Private Equity | 01/01/2008 |
Schroder Salomon Smith Barney International Ltd.
 Schroder Salomon Smith Barney International Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 19/05/2003 |
FAB Pharma SAS
 FAB Pharma SAS Miscellaneous Commercial ServicesCommercial Services Develops drugs for the treatments of bacterial infections | Direttore/Membro del Consiglio | - |
Formazione di Florian Reinaud
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
15
Relazioni di 1° grado
18
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 18 |
|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altaroc Partners SA
Altaroc Partners SA Investment ManagersFinance Altaroc Partners invests in companies located across the globe primarily in Europe and North America. The firm targets companies operating in the fields of technology, healthcare, b2b services and digital consumer. It provides financing for LBO's and buyout transactions. It also makes co-investments. | Finance |
Schroder Salomon Smith Barney
 Schroder Salomon Smith Barney Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
Kuros Biosurgery Holding AG
 Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs for biosurgery, tissue repair and regeneration | Commercial Services |
Innovation Capital SASU
Innovation Capital SASU Investment ManagersFinance Innovation Capital is an active manager which specializes in technology venture capital, investing in both early- and late-stage businesses with distinctive technology and high-growth potential, within the information technology and life sciences industries. They have invested in sectors including information and communication technologies, clean technologies, advanced materials, robotics, healthcare, biotechnologies and medical technologies. The firm seeks to invest in companies with a dynamic management team with execution capacity, a sizeable growth market, immediate user relevance, competitive advantages, reasonable development cost, intellectual property potential, and a sustainable business model. Innovation Capital aims to foster the growth of their investee companies through advisory consulting and networking opportunities. They lead the first and subsequent financing round or co-invest in re-financing rounds. They follow a pragmatic investment approach, are actively involved in the management of their investee companies and seek board representation. | Finance |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Praxim SA
 Praxim SA Medical SpecialtiesHealth Technology Develops and commercializes surgical robots, manual instruments & related software solutions | Health Technology |
Schroder Salomon Smith Barney International Ltd.
Schroder Salomon Smith Barney International Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Voluntis SA
 Voluntis SA Packaged SoftwareTechnology Services Develops anti-cancer treatment platform | Technology Services |
Scancell Holdings Plc
 Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
OMNI Orthopaedics, Inc.
 OMNI Orthopaedics, Inc. Medical SpecialtiesHealth Technology Designs, manufactures, and distributes orthopedic implants | Health Technology |
FAB Pharma SAS
FAB Pharma SAS Miscellaneous Commercial ServicesCommercial Services Develops drugs for the treatments of bacterial infections | Commercial Services |
Sensorion SA
 Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Concilio | |
Sensome SAS
Sensome SAS Electronic Equipment/InstrumentsElectronic Technology Develops remote monitoring invasive vascular medical devices | Electronic Technology |
